The infection control market is projected to reach USD 27.5 billion by 2024 from USD 20.0 billion in 2019, at a CAGR of 6.6% during the forecast period. The increasing burden of HAIs and SSIs, the increasing number of hospital visits owing to a growing geriatric population and the rising burden of chronic diseases, and growth in the pharmaceutical and medical device industries are expected to drive this market during the forecast period.

The global infection control market is a fragmented market and is operated by a number of large and small players. However, each product segment is dominated by a few key players, which dominate the majority of the market. Getinge AB (Sweden), STERIS plc (US), Advanced Sterilization Products (US), Sotera Health (US), and Belimed AG (Switzerland) are some leading players in the sterilization equipment and cleaning and disinfection product segments. 3M (US) and Ecolab (US) are the leading players in the disinfectants and other consumables market, alongside Getinge AB (Sweden), STERIS plc (US), and Advanced Sterilization Products (US). Product launches and acquisition are the main strategies adopted by these players to strengthen their position in the market.

STERIS dominated the global sterilization products and services market in 2018. The company derives most of its revenues from North America, specifically the US market. The company has a strong portfolio for the sterilization equipment market. To further expand and maintain its leading market position, STERIS focuses both organic and inorganic strategies, such as product launches, acquisitions, and agreements. For instance, in September 2017, Steris acquired Harwell Dosimeters Limited (UK) to provide comprehensive contract sterilization and laboratory testing services to its global customers. Besides, product launches such as AMSCO 430LS and the 630LS Sterilizers in August 2017 and AMSCO 110LS and 250LS Small Steam Sterilizers in April 2016, have helped the company offer innovative solutions to its customers worldwide.

Getinge Group:The Getinge Group held the second position in the global sterilization products and services market in 2018. The company derives a majority of its revenue from the developed regions of North America and Europe. The company focuses on inorganic growth strategies, such as agreements and acquisitions, which enable it to further strengthen its market position. For instance, in April 2016, Getinge signed an agreement with the Pharmaceutical Management Agency (New Zealand) under which Getinge would provide sterilization assurance indicators to DHB hospitals. In addition, in December 2015, the company acquired Stericool (Turkey), which specializes in low-temperature sterilization. This acquisition enabled the company to strengthen its offerings in the sterilization solutions market. Besides, in 2018, the company launched the GSS Steam Sterilizer series, which will favor the company’s position in the market.